Jefferies Upgrades Onyx Pharmaceuticals (ONXX) to Buy; FDA Approves Kyprolis; Takeover Speculation Intensifies
Go back to Jefferies Upgrades Onyx Pharmaceuticals (ONXX) to Buy; FDA Approves Kyprolis; Takeover Speculation Intensifies| NOVARTIS AG (NYSE: NVS) | Delayed: 160.31 +5.76 (3.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.55 | 52 Week High | $89.15 | |||
| Open | $156.29 | 52 Week Low | $69.84 | |||
| Day High | $160.81 | P/E | N/A | |||
| Day Low | $156.17 | EPS | $0.00 | |||
| Volume | 2,400,551 | |||||
| Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) | Delayed: 124.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.70 | 52 Week High | $136.87 | |||
| Open | $124.70 | 52 Week Low | $68.12 | |||
| Day High | $124.70 | P/E | N/A | |||
| Day Low | $124.70 | EPS | $-1.58 | |||
| Volume | 514,854 | |||||
